We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hallucinations, anxiety and depression, as well as changes in behaviour and mood. Healthcare professionals...
Employment Appeal Tribunal Judgment of Judge Tayler on 30 April 2024.
Employment Appeal Tribunal Judgment on Recusal Application of Judge Tayler on 30 April 2024.
Paper prepared by the Data Evaluation and Learning for Viral Epidemics (DELVE) group in the Royal Society.
Rapid review prepared by UNCOVER on face masks for the general population.
This paper explores local perceptions during, and after, volcanic crises in Yogyakarta, near Gunung Merapi volcano in Indonesia
Guidance for people who have been diagnosed with a mpox infection and who have been advised to self-isolate at home.
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
Community Wearability Assessment of Respiratory Protection against Volcanic Ash from Mt Sinabung, Indonesia
Community wearability assessment of respiratory protection against volcanic ash from Mt Sinabung, Indonesia
Information and advice on cleaning sex-on-premises venues.
Further measures to be introduced to ensure patients who are prescribed montelukast for the treatment of asthma are informed of the risk of neuropsychiatric reactions
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
Product Recall for 3M Face Shield presenting a risk of kinetic energy/high-speed flying particles.
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.